CORRECTING AND REPLACING -- CardioGenics Announces $1.3 Million Private Placement to European Investors
GlobeNewswire - Thu Jun 12, 4:00PM CDT
Please replace the release with the following corrected version due to an incorrect date in the last paragraph of the release, which should read "... late July 2014" instead of "... late July 2013."
CardioGenics Announces $1.3 Million Private Placement to European Investors
GlobeNewswire - Thu Jun 12, 9:04AM CDT
CardioGenics Holdings Inc. (OTCBB:CGNH), developer of the QL Care(TM) analyzer, an ultra-sensitive immunoassay point-of-care analyzer, and other products targeting the In-Vitro Diagnostics testing market, today announced it has sold $1.3 million of its common stock in a private placement to European institutional and other investors. Closing of the transaction is subject to listing of the shares on the NewConnect Market of the Warsaw Stock Exchange. WDM acted as offering agent and leading financial advisor on the transaction.